3
A.; Avory, M.; Trigg, W. Bioorg. Med. Chem. Lett. 2012, 22,
5795.
the corresponding phosphonium salt, (2-methyl-5,6,7,8-
tetrahydroquinazolin-4-yl)(triphenyl)phosphonium fluoride in
95% yield (see Supplementary data).
9. (a) Doherty, E. M.; Fotsch, C.; Bannon, A. W.; Bo, Yu.; Chen, N.;
Dominguez, C.; Falsey, J.; Gavva, N. R.; Katon, J.; Nixey, T.;
Ognyanov, V. I.; Pettus, L.; Rzasa, R. M.; Stec, M.; Surapaneni,
S.; Tamir, R.; Zhu, J.; Treanor, J. J. S.; Norman, M. H. J. Med.
Chem. 2007, 50, 3515. (b) Wang, H.-L.; Katon, J.; Balan, C.;
Bannon, A. W.; Bernard, C.; Doherty, E. M.; Dominguez, C.;
Gavva, N. R.; Gore, V.; Ma, V.; Nishimura, N.; Surapaneni, S.;
Tang, P.; Tamir, R.; Thiel, O.; Treanor, J. J. S.; Norman, M. H. J.
Med. Chem. 2007, 50, 3528.
10. (a) Alty, A. C.; Banks, R. E.; Fishwick, B. R.; Pritchard, R. G.;
Thompson A. R. J. Chem. Soc., Chem. Commun. 1984, 832. (b)
Kuduk, S. D.; Di Marco, C. N.; Chang, R. K.; Ray, W. J.; Mab, L.;
Wittmann, M.; Seager, M. A.; Koeplinger, K. A.; Thompson, C.
D.; Hartman, G. D.; Bilodeau M. T. Bioorg. Med. Chem. Lett.
2010, 20, 2533.
11. (a) Rossom, W. V.; Robeyns, K.; Ovaere, M.; Meervelt, L. V.;
Dehaen, W.; Maes, W. Org. Lett. 2011, 13, 126. (b) Ranjbar-
Karimi, R.; Sandford, G.; Yufit, D. S.; Howard J. A. K. J.
Fluorine Chem. 2008, 129, 307.
12. (a) Brown, D. J. In The Chemistry of Heterocyclic Compounds:
The Pyrimidines; Brown, D. J., Ed.; John Wiley & Sons: New
York, 1994, Vol. 52, pp. 345–347. (b) Gebhardt, P.; Saluz, H. P.
ARKIVOC, 2012, 159. (c) Bennett, B. K.; Harrison, R. G.;
Richmond, T. G. J. Am. Chem. Soc. 1994, 116, 11165. (d) Andres,
P.; Marhold, A. J. Fluorine Chem. 1996, 77, 93. (e) Yoneda, N.;
Fukuhara, T. Tetrahedron, 1996, 52, 23. (f) Darabantu, M.;
Lequeux, T.; Pommelet, J.-C.; Ple, N.; Turck, A. Tetrahedron,
2001, 57, 739.
23. General procedure for the reduction of pyrimidine N-oxides 2a–g:
PCl3 (27.4 mg, 0.017 ml, 0.2 mmol) was added dropwise to a
stirred solution of pyrimidine N-oxide 2a–g (0.1 mmol) in CHCl3
(1 ml) and the mixture was refluxed for 2 h. Then it was allowed
to cool to r.t. and quenched with an equal amount of ice–water.
The organic phase was separated and the water phase extracted
with CHCl3 (3×1 mL). The combined organic layers were washed
with a saturated solution of NaHCO3 (3 ml) and with H2O (3 ml)
and dried over MgSO4. The solvent was evaporated in vacuo, the
purities of compounds 3a–g was above 95%.
24. 4-Fluoro-5,6,7,8-tetrahydro-2-methylquinazoline (3a). Yield 68%
(11.3 mg) from 2a (18.2 mg), Rf=0.2 (petroleum ether:CHCl3,
1:1), colorless oil. 1H NMR (400.0 MHz, CDCl3) δ: 1.76–1.92 (m,
4H, 2CH2), 2.59 (s, 3H, CH3), 2.64 (br t, 2H, 3JHH 6.2 Hz, CH2),
2.83 (br t, 2H, 3JHH 6.3 Hz, CH2); 13C NMR (100.6 MHz, CDCl3)
δ: 20.6 (CH2), 21.4 (CH2), 21.9 (CH2), 25.2 (CH3), 31.7 (3JCF 5 Hz,
CH2), 112.8 (2JCF 27 Hz, C4a), 165.1 (3JCF 14 Hz, C2), 167.6 (1JCF
251 Hz, CF), 170.2 (3JCF 7 Hz, С8a); 19F NMR (376.3 MHz,
CDCl3) δ: -68.14 (s, 1F). HRMS (ESI): calcd for C9H11FN2
[M+H]+: 167.0979. Found: 167.0988.
25. 4-Fluoro-2-methyl-6-phenylpyrimidine (3f).Yield 95% (17.9 mg)
from 2f (20.4 mg), Rf=0.6 (CHCl3), colorless oil. 1H NMR (400.0
MHz, CDCl3) δ: 2.74 (s, 3H, CH3), 7.12 (br s, 1H, CH, Pyr), 7.49–
7.52 (m, 3H, 3CH, Ph), 8.03–8.07 (m, 2H, 2CH, Ph); 13C NMR
(100.6 MHz, CDCl3) δ: 25.9 (CH3), 99.1 (2JCF 31 Hz, C5), 127.3
(2CH, Ph), 129.0 (2CH, Ph), 131.3 (CH, Ph), 136.0 (4JCF 5 Hz, C,
Ph), 168.8 (3JCF 7 Hz, C6), 169.4 (3JCF 14 Hz, C2), 170.7 (1JCF 250
Hz, C4); 19F NMR (376.3 MHz, CDCl3) δ: -61.38 (s, 1F). HRMS
(ESI): calcd for C11H9FN2 [M+H]+: 189.0823. Found: 189.0823.
26. Column chromatography was performed on aluminum oxide
―Acros organics‖ (activated, neutral, 50–200 micron). Employing
aluminum oxide, previously dried at 400 oC, led to complete
decomposition of compound 3a.
27. See for example: (a) Varma, R. S.; Lamture, J. B.; Varma M.
Tetrahedron Lett. 1993, 34, 3029. (b) Hondrogiannis, G.; Tan, L.
Ch.; Pagni, R. M.; Kabalka, G. W.; Herold, S.; Ross, E.; Green, J.;
McGinnis M. Tetrahedron Lett. 1994, 35, 6211. (c) Wilgus, C. P.;
Downing, S.; Molitor, E.; Bains, S.; Pagni, R. M.; Kabalka, G. W.
Tetrahedron Lett. 1995, 36, 3469. (d) Debnath, K.; Pathak S.;
Pramanik, A. Tetrahedron Lett. 2013, 54, 896.
13. (a) Chi, K.-W.; Furin, G. G.; Gatilov, Yu. V.; Bagryanskay, I. Yu.;
Zhuzhgov, E. L. J. Fluorine Chem. 2000, 103, 105. (b) German,
L. S.; Postovoi, S. A.; Kagramanova, E. M.; Zeifman Yu. V. Russ.
Chem. Bull. 1997, 46, 1920. (c) Inouye, Y.; Higuchij, Y. J.
Fluorine Chem.1985, 27, 231. (d) Chambers, R. D.; Musgrave, W.
K. R.; Sargent, C. R. J. Chem. Soc., Perkin Trans. 1, 1981, 1071.
(e) de Nanteuil, G. Tetrahedron Lett. 1991, 32, 2467. (f) Inouye,
Y.; Tezuka, K.; Takeda, W.; Sugai, S. J. Fluorine Chem. 1987, 35,
275. (g) Kovregin, A. N.; Sizov, A. Yu.; Ermolov, A. F. Russ.
Chem. Bull., Int. Ed. 2002, 51, 1020.
14. Sedenkova, K. N.; Averina, E. B.; Grishin, Yu. K.; Kutateladze,
A. G.; Rybakov, V. B.; Kuznetsova, T. S.; Zefirov, N. S.; J. Org.
Chem. 2012, 77, 9893.
15. Yamanaka, H. Chem. Pharm. Bull. 1959, 7, 158.
16. Ranganathan, D.; Bamezai, S.; Ramachandran, P. V.
Heterocycles, 1985, 23, 623.
17. Yamanaka, H.; Sakamoto, T. Heterocycles, 1977, 7, 51.
18. Howard, E. Jr.; Olszewski W. F. J. Am. Chem. Soc.
1959, 81, 1483.
19. (2-Methyl-1-oxido-5,6,7,8-tetrahydroquinazolin-4-
yl)(triphenyl)phosphonium fluoride (4). PPh3 (350.0 mg, 1.32
mmol) was added to a solution of tetrahydroquinazoline N-oxide
2a (80.0 mg, 0.44 mmol) in MeCN (1 ml) and the reaction mixture
was refluxed for 48 h. After cooling to r.t., the solvent was
evaporated in vacuo. The solid residue was washed with Et2O (10
ml) to remove the excess of PPh3. Yield 79% (154.5 mg), white
amorphous solid, Rf=0.9 (CHCl3: CH3OH, 1:1). 1H NMR (400.0
MHz, CDCl3) δ: 1.56–1.64 (m, 2H, CH2(6)), 1.80–1.90 (m, 2H,
CH2(7)), 2.12 (br t, 2H, 3JHH 6.2 Hz, CH2(5)), 2.54 (s, 3H, CH3),
2.93 (br t, 2H, 3JHH 6.5 Hz, CH2(8)), 7.65-7.71 (m, 6H, 6CH, Ph),
7.72-7.80 (m, 6H, 6CH, Ph), 7.83-7.90 (m, 3H, 3CH, Ph); 13
C
NMR (100.6 MHz, CDCl3) δ: 19.7 (CH3), 20.1 (CH2(7)), 20.7
(CH2(6)), 25.3 (CH2(8)), 27.6 (CH2(5)), 116.8 (1JCP 89, 3C, Ph),
129.5 (1JCP 124 Hz, C4), 130.7 (JCP 13 Hz, 6CH, Ph), 134.5 (JCP
10 Hz, 6CH, Ph), 135.7 (4JCP 3 Hz, 3CH, Ph), 137.9 (2JCP 25 Hz,
C4a), 157.7 (3JCP 11 Hz, C8a), 158.7 (3JCP 23 Hz, C2); 31P NMR
(161.9 MHz, CDCl3) δ: 19.05 (s, 1P); 19F NMR (376.3 MHz,
CDCl3) δ: –152.87 (s, 1F). HRMS (ESI): calcd for [C27H26N2OP+]:
425.1777. Found: 425.1763.
20. (a) Egg, H.; Richter, W.; Bretschneider, H. Monash. Chem., 1969,
100, 518. (b) Okui, K.; Ito, K.; Kametani, T. J. Heterocycl. Chem.
1972, 9, 821. (c) Weiss, R., May, R.; Pomrehn, B. Angew. Chem.
1996, 108, 1319.
21. (a) Beletskaya, I. P.; Kazankova, M. A. Russ. J. Org. Chem.,
2002, 38, 1391. (b) Marcoux, D.; Charette, A. B. J. Org. Chem.
2008, 73, 590.
22. Obtained later in the course of this work, 4-fluorotetrahydroquina-
zoline 3a was found to be even more reactive in this process. The
reaction of 3a with PPh3 proceeded at r.t. in CHCl3 and afforded